Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 6, 2003, Pages 993-1000

  Philpott Howard, John ^a   Burroughs, Andrew ^b   Fisher, Neil ^c,f   Hastings, Mark ^c,g   Kibbler, Christopher ^d   Mutimer, David ^c   Patch, David ^b   Rolando, Nancy ^b   Wade, Jim ^e   Wendon, Julia ^e   O'Grady, John ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f RUSSELLS HALL HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Antibiotic therapy; Infection; Liver transplant; Randomized controlled trial

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL DISTENSION; ADOLESCENT; ADULT; AGED; ANAEROBIC INFECTION; ANEURYSM; ANGINA PECTORIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BILIARY COLIC; BLEEDING; BRAIN DISEASE; CHEMICAL PARAMETERS; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; CYANOSIS; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DYSPNEA; ENTEROCOCCUS FAECIUM; FEMALE; FEVER; GRAFT REJECTION; GRAM NEGATIVE BACTERIUM; HEART ARREST; HEART FAILURE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPOGLYCEMIA; HYPOXIA; KLEBSIELLA; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; MULTICENTER STUDY; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; STOMACH PERFORATION; TREATMENT OUTCOME; URINE INCONTINENCE;

EID: 10744230520     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg463     Document Type: Article

References (38)

1. Cuervas-Mons, V., Millan, I., Gavaler, J. S. et al. (1986). Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 6, 922-7.
2. Cuervas-Mons, V., Julio Martinez, A., Dekker, A. et al. (1986). Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology 6, 495-501.
3. Kusne, S., Dummer, J. S., Singh, N. et al. (1988). Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine 67, 132-43.
4. Martin, M., Kusne, M., Alessiani, R. et al. (1991). Infections after liver transplantation: risk factors and prevention. Transplantation Proceedings 23, 1929-30.
5. Castaldo, P., Stratta, R. J., Wood, R. P. et al. (1991). Clinical spectrum of fungal infections after orthotopic liver transplantation. Archives of Surgery 126, 149-56.
6. Patel, R. & Paya, C. (1997). Infections in solid-organ transplant recipients. Clinical Microbiology Reviews 10, 86-124.
7. Patel, R., Portela, D., Badley, A. D. et al. (1996). Risk factors of invasive candida and non-candida fungal infections after liver transplantation. Transplantation 62, 926-34.
8. Collins, L. A., Samore, M. H., Roberts, M. S. et al. (1994). Risk factors for invasive fungal infection complicating orthotopic liver transplantation. Journal of Infectious Diseases 170, 644-52.
9. Singh, N., Gayowski, T., Wagener, M. M. et al. (1997). Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. European Journal of Clinical Microbiology and Infectious Diseases 16, 821-6.
10. Wade, J. J., Rolando, N., Hayllar, K. et al. (1995). Bacterial and fungal infection after liver transplantation: an analysis of 284 patients. Hepatology 21, 1328-36.
11. Moulin, D., Clement de Clety, S., Reynaert, M. et al. (1989). Intensive care for children after orthotopic liver transplantation. Intensive Care Medicine 15, S711-S72.
12. Paya, C. V., Hermans, P. E., Washington, J. A., II et al. (1989). Incidence, distribution and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clinic Proceedings 64, 554-64.
13. Lumbreras, C., Lizasoain, M., Moreno, E. et al. (1992). Major bacterial infections following liver transplantation: a prospective study. Hepatogastroenterology 39, 362-5.
14. Martinez-Ibañez, V., Iglesias, J., Llorret, J. et al. (1993). Experiencia de siete años en el transplante hepático pediátrico [7 years' experience with hepatic transplantation in children]. Cirugia Pediatrica 6, 7-10.
15. Barkholt, L., Ericzon, B. G., Tollemar, J. et al. (1993). Infections in human liver recipients: different patterns early and late after transplantation. Transplant International 6, 77-84.
16. Kizilisik, T. A., Larsen, I. M., Bain, V. G. et al. (1993). Liver transplantation at the University of Alberta Hospitals: a review of the first three years. Transplantation Proceedings 25, 2203-5.
17. Uemoto, S., Tanaka, K., Fujita, S. et al. (1994). Infectious complications in living related liver transplantation. Journal of Pediatric Surgery 29, 514-7.
18. Singh, N., Gayowski, T., Wagener, M. et al. (1996). Pulmonary infections in liver transplant recipients receiving tacrolimus. Transplantation 61, 396-401.
19. Wiesner, R. H. (1990). The incidence of Gram-negative bacterial and fungal infections in liver transplant patients treated with selective decontamination. Infection 18, S19-S21.
20. Wiesner, R. H. (1991). Selective bowel decontamination for infection prophylaxis in liver transplantation patients. Transplantation Proceedings 23, 1927-8.
21. Gotzinger, P., Sautner, T., Wamser, P. et al. (1996). Early postoperative infections after liver transplantation - pathogen spectrum and risk factors. Wiener Klinische Wochenschrift 108, 795-801.
22. Badger, I. L., Crosby, H. A., Kong, K. L. et al. (1991). Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim result of a prospective, randomised trial. Transplantation Proceedings 23, 1460-1.
23. Smith, S. D., Jackson, R. J., Hannakan, C. J. et al. (1993). Selective decontamination in paediatric liver transplants. Transplantation 55, 1306-9.
24. Kusne, S., Fung, J., Alessiani, M. et al. (1992). Infections during a randomised trial comparing cyclosporine to FK506 immunosuppression in liver transplantation. Transplantation Proceedings 24, 429-30.
25. Whiting, J. F., Rossi, S. J. & Hanto, D. W. (1997). Infectious complications after OKT3 induction in liver transplantation. Liver Transplantation and Surgery 3, 563-70.
26. Hadley, S., Samore, M. H., Lewis, W. D. et al. (1995). Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 59, 851-9.
27. Arnow, P. M., Carandang, G. C., Zabner, R. et al. (1996). Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases 22, 997-1003.
28. Murcia, J., Vasquez, J., Hierro, L. et al. (1990). La infección como complicación del transplante hepático [Infection as a complication of the liver transplant]. Cirugia Pediatrica 3, 121-4.
29. Ascher, N. L., Stock, P. G., Bumgardner, G. L. et al. (1988). Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surgery Gynecology and Obstetrics 167, 474-8.
30. Colonna, J. O., Winston, D. J., Brill, J. E. et al. (1988). Infectious complications in liver transplantation. Archives of Surgery 123, 360-4.
31. George, D. L., Arnow, P. M., Fox, A. S. et al. (1991). Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Review of Infectious Diseases 13, 387-96.
32. Jacobs, F., Van De Stadt, J., Bourgeois, N. et al. (1989). Severe infections early after liver transplantation. Transplantation Proceedings 21, 2271-3.
33. Rolando, N. & Wade, J. (1999). Liver transplantation: prevention and treatment of infection. In Evidence Based Gastroenterology and Hepatology (McDonald, J. W. D., Burroughs, A. K. & Feagan, B. G., Eds), pp. 512-27. British Medical Journal Books, London, UK.
34. Singh, N., Gayowski, T., Rihs, J. D. et al. (2001). Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transplantation 7, 22-6.
35. European Organization for Research and Treatment of Cancer Group. (1991). Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. Journal of Infectious Diseases 163, 951-8.
36. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. (1993). Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. British Medical Journal 307, 525-32.
37. van Enckevort, P. J., Zwaveling, J. H., Bottema, J. T. et al. (2001). Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics 19, 523-30.
38. Zwaveling, J. H., Maring, J. K., Klompmaker, I. J. et al. (2002). Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Critical Care Medicine 30, 1204-9.